| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | Options Exercise | $153,017 | +4,087 | +3.7% | $37.44 | 113,127 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | $153,100 | -1,175 | -1% | $130.30 | 111,952 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Tax liability | $149,322 | -1,146 | -1% | $130.30 | 110,806 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Options Exercise | $333,294 | +4,074 | +3.7% | $81.81 | 114,880 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Disposed to Issuer | $333,359 | -2,558 | -2.2% | $130.32 | 112,322 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Tax liability | $77,801 | -597 | -0.53% | $130.32 | 111,725 | 10 May 2024 | Direct | |
| transaction | EOG | Common Stock | Sale | $230,092 | -1,766 | -1.6% | $130.29 | 109,959 | 13 May 2024 | Direct | |
| transaction | EOG | Common Stock | Sale | $119,747 | -919 | -0.84% | $130.30 | 109,040 | 13 May 2024 | Direct | |
| holding | EOG | Common Stock | 8,000 | 10 May 2024 | Family Trust (AD) | ||||||
| holding | EOG | Common Stock | 8,000 | 10 May 2024 | Family Trust (KD) | ||||||
| holding | EOG | Common Stock | 8,000 | 10 May 2024 | Family Trust (PD) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4,087 | -100% | $0.000000* | 0 | 10 May 2024 | Common Stock | 4,087 | $37.44 | Direct | F1 |
| transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -4,074 | -50% | $0.000000 | 4,087 | 10 May 2024 | Common Stock | 4,074 | $81.81 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in increments of 33.3%, 33.3%, and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. |
| F2 | The SARs granted become exercisable in increments of 33.3%, 33.3%, and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted become fully exercisable on September 27, 2024. |